Murray Goldberg

Murray Goldberg

Direktör/Styrelseledamot på AYALA PHARMACEUTICALS, INC.
81 år
Health Technology
Consumer Services
Finance

Profil

Mr. Murray A. Goldberg is an Independent Director at Ayala Pharmaceuticals, Inc. and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Ayala Pharmaceuticals, Inc. Mr. Goldberg was previously employed as an Independent Director by Ayala Pharmaceuticals, Inc. /Old/, an Independent Director by Teva Pharmaceutical Industries Ltd., an Independent Director by Aerie Pharmaceuticals, Inc., a Senior Vice President-Administration by Regeneron Pharmaceuticals, Inc., a Chief Financial Officer, Treasurer & VP-Finance by PharmaGenics, Inc., and a Managing Director-Structured Finance Group by The Chase Manhattan Bank NA. He also served on the board at Advaxis, Inc. He received his undergraduate degree from New York University, a graduate degree from London School of Economics & Political Science and an MBA from The University of Chicago.

Aktiva positioner av Murray Goldberg

FöretagPositionStart
AYALA PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2023-01-01
Konsult / Rådgivare -

Tidigare kända positioner av Murray Goldberg

FöretagPositionSlut
ADVAXIS, INC. Direktör/Styrelseledamot 2023-01-19
AERIE PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2020-06-11
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Direktör/Styrelseledamot 2020-06-09
REGENERON PHARMACEUTICALS, INC. Finansdirektör/CFO 2013-10-03
Finansdirektör/CFO 1995-01-01
Se detaljerna i Murray Goldbergs erfarenhet

Murray Goldbergs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

69

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Murray Goldberg